#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigus Ornithine transcarbamoylase deficiency Hereditary motor and sensory neuropathy Neuroendocrine carcinoma metastatic Epidermolysis bullosa Marginal zone lymphoma Thymic carcinoma Hyperoxaluria Anal cancer Osteosarcoma metastatic Vernal keratoconjunctivitis Mantle cell lymphoma stage II Autoimmune demyelinating disease Malformation venous Mucopolysaccharidosis I More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma Glycogen storage disease type V – Treatment Pituitary-dependent Cushing’s syndrome – Diagnostics Cystic fibrosis – Treatment Behcet’s syndrome – Basic Information Erdheim-Chester disease – Treatment Mucopolysaccharidosis II Myelodysplastic syndrome – Treatment Loeys-Dietz syndrome – Diagnostics Paraneoplastic neurological syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxybuprocaine Human Mesenchymal Stem Cells Hydrocortisone Acetate Chlorambucil SODIUM FUSIDATE Olodaterol Irbesartan Thiamine Nitrate Bp Oteracil SPY002 Nandrolone Decanoate Iomeprol CIRTUVIVINT Gen3017 Acetic Acid, Glacial Ro7589655 ARGININE GLUTAMATE Protease Cft1946 AZD4360 More therapies…

    Learn about Your Condition

    Vascular malformation Necrotising myositis Lymphatic malformation Laparoscopic surgery Lysosomal storage disorder Colorectal adenocarcinoma Gastrointestinal melanoma Biliary neoplasm Laryngeal cancer stage II Bone marrow failure Piriformis syndrome Conjunctivitis Vulvovaginal discomfort Chronic hepatitis C Epithelioid sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metformin
    • Metformin Hydrochloride
    Germany

  • Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment

    Recruiting

    4 1 1
    Germany Italy The Netherlands Spain

  • Study of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Belgium Germany Italy Spain

  • Study of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread

    Recruiting

    1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    Investigated Drugs:
    • GSK5764227
    Belgium Finland France Germany Italy The Netherlands +4

  • Study of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Doxorubicin Hydrochloride, Liposomal
    • Patritumab Deruxtecan
    • Capecitabine
    France Germany Greece Hungary Italy Poland +1

  • Study of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
    Bulgaria Estonia Italy Poland Spain
Previous Page
1 … 153 154 155 156 157 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!